培训课件_达托霉素演示文稿.pptVIP

  • 389
  • 0
  • 约6.79千字
  • 约 36页
  • 2016-11-22 发布于浙江
  • 举报
万古霉素PTA达成与肾毒性的关系 Clinical Infectious Diseases 2011;52(8):969–974 MRSA 万古霉素 1.0 Q8H 万古霉素 1.0 Q12H 达托霉素500mg Qd ? 患者感染的来自哪里? 治疗过程中培养到的MRSA是否就是原致病菌? 来源:咽喉部感染,链球菌、厌氧菌? 青霉素+酶复合制剂、阿米卡星 MRSA :院内感染 * * * Invasive infections caused by methicillin-resistant Staphylococcusaureus (MRSA) have become a major public health problem in the United States,with bloodstream infections(BSIs) accounting for 75%of the invasive cases. Vancomycin was the treatment of choice and was prescribed as empiricaltherapy in 75% of the patients in this surveillance study. However, MRSA strains exhibiting dif

文档评论(0)

1亿VIP精品文档

相关文档